Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell; Autologous Stem Cell Transplantation Interventions: Other: Apheresis; Other: Autologous Stem Cell Transplantation; Drug: CAR-T Cell Therapy Sponsors: The First Affiliated Hospital of Soochow University; Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd; Suzhou Hongci Hematology Hospital, Suzhou, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients
Conditions: T-ALL; Haploidentical Hematopoietic Stem Cell Transplantation; Cord Blood Interventions: Biological: Haplo-cord HCT; Biological: Haplo-HCT Sponsors: The First Affiliated Hospital of Soochow University; Children ' s Hospital of Soochow University; Ruijin Hospital; Nanfang Hospital, Southern Medical University; Fujian Medical University Union Hospital; First Affiliated Hospital Xi ' an Jiaotong University; Wuhan Union Hospital, China; Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
Conditions: Autologous Stem Cell Transplant; Classic Hodgkin Lymphoma Interventions: Drug: Pembrolizumab; Procedure: Autologous stem cell transplant; Drug: Carmustine; Drug: Etoposide; Drug: Cytarabine; Drug: Melphalan Sponsors: Masonic Cancer Center, University of Minnesota Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia Interventions: Drug: Modified transplantation system Sponsors: Hematology department of the 920th hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Daratumumab for Patients With Light Chain Amyloidosis
Conditions: Light Chain (AL) Amyloidosis Interventions: Drug: Dratumumab / Hyaluronidase Injection [Darzalex Faspro]; Drug: Pomalidomide 4 MG; Procedure: autologous stem cell transplantation (ASCT) Sponsors: Nanjing University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Placenta Derived Stem Cells for Treating of Chronic Ulcers and Neuropathy
Conditions: Diabetic Foot; Diabetic Neuropathies; Diabetic Foot Ulcer Interventions: Biological: Transplantation of Placenta Derived Stem Cells Sponsors: Michael H Carstens; Ministerio de Salud de Nicaragua; Wake Forest Institute for Regenerative Medicine Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Pneumatic Reduction For Intussusception In Children: A Retrospective Cohort Study
Conditions: Intussusception Interventions: Procedure: Fluoroscopic-guided air-enema reduction (FGAR) Sponsors: National Children ' s Hospital, Vietnam; Vinmec Research Institute of Stem Cell and Gene Technology Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors
Conditions: B-NHL, Extranodal, TP53 Alterations, Bulky Mass Interventions: Biological: autologous stem-cell transplantation, Relmacabtagene autoleucel (relma-cel) Sponsors: Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction
Conditions: Acute Myocardial Infarction Interventions: Biological: Autologous Peripheral Blood Stem Cell injection Sponsors: Seoul National Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Fatigue and Cognitive Dysfunction After Allogeneic Stemcell Transplantation, Prospective PET Study
Conditions: Fatigue; Cognitive Dysfunction Sponsors: Karolinska Institutet; Karolinska University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Varying Bone Marrow-Derived Mesenchymal Stem Cells Concentrations' Impact on Rotator Cuff Repair Outcomes
Conditions: Rotator Cuff Tears Interventions: Other: Rotator cuff repair augmented with whole bone marrow; Other: Rotator cuff repair augmented with concentrated bone marrow Sponsors: Johns Hopkins University; ON Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen
Conditions: CMV Infection or Reactivation After Allogenic HSCT Sponsors: Siriraj Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain
Conditions: Low Back Pain Interventions: Biological: Lumbar Injections with 10cc ' s of Wharton ' s Jelly Allograft Sponsors: R3 Stem Cell; R3 Medical Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis; Secondary-Progressive Multiple Sclerosis; Mesenchymal Stem Cells Interventions: Biological: Allogenic placenta derived mesenchymal stem cells Sponsors: Tehran University of Medical Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
MiSaver ® Stem Cell Treatment for Acute Myocardial Infarction
Conditions: Acute Myocardial Infarction Interventions: Drug: MiSaver Sponsors: Honya Medical Inc; Chung Shan Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
